author-photo

Joy Miyashiro

Ironwood Pharmaceuticals

4

Papers

32

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Pharmacological Characterization of IW-1973, a Novel Soluble Guanylate Cyclase Stimulator with Extensive Tissue Distribution, Antihypertensive, Anti-Inflammatory, and Antifibrotic Effects in Preclinical Models of Disease

2018 Journal of Pharmacology and Experimental Therapeutics
Show All
- Source
- Cite
- Save
Citations (28)
The Effect of the Soluble Guanylyl Cyclase Stimulator Olinciguat on ƴ-Globin Gene Induction in K562 Cells

2018 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Discovery of IWP-051, a novel orally bioavailable soluble guanylate cyclase stimulator with sustained and dose-dependent hemodynamic effects.

2015 BMC Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (2)
P158 – IWP-051, a novel, orally available small molecule soluble guanylate cyclase (sGC) stimulator with once-daily dosing potential for the treatment of cardiovascular diseases

2014 Nitric Oxide
Show All
- Source
- Cite
- Save
Citations (1)